219 related articles for article (PubMed ID: 23615186)
1. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
[TBL] [Abstract][Full Text] [Related]
2. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
[TBL] [Abstract][Full Text] [Related]
3. Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.
Di Nunzio F; Maruggi G; Ferrari S; Di Iorio E; Poletti V; Garcia M; Del Rio M; De Luca M; Larcher F; Pellegrini G; Mavilio F
Mol Ther; 2008 Dec; 16(12):1977-85. PubMed ID: 18813277
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors.
Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F
PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment in skin gene therapy: viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors.
Almarza D; Bussadori G; Navarro M; Mavilio F; Larcher F; Murillas R
Gene Ther; 2011 Jul; 18(7):674-81. PubMed ID: 21368897
[TBL] [Abstract][Full Text] [Related]
6. A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.
Serrano F; Del Rio M; Larcher F; Garcia M; Muñoz E; Escamez MJ; Muñoz M; Meana A; Bernad A; Jorcano JL
Hum Gene Ther; 2003 Nov; 14(16):1579-85. PubMed ID: 14577919
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
8. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
9. RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.
Zaiss AK; Son S; Chang LJ
J Virol; 2002 Jul; 76(14):7209-19. PubMed ID: 12072520
[TBL] [Abstract][Full Text] [Related]
10. The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.
Haas DL; Lutzko C; Logan AC; Cho GJ; Skelton D; Jin Yu X; Pepper KA; Kohn DB
J Virol; 2003 Sep; 77(17):9439-50. PubMed ID: 12915559
[TBL] [Abstract][Full Text] [Related]
11. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
[TBL] [Abstract][Full Text] [Related]
12. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
14. Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.
Métais JY; Topp S; Doty RT; Borate B; Nguyen AD; Wolfsberg TG; Abkowitz JL; Dunbar CE
Gene Ther; 2010 Jun; 17(6):799-804. PubMed ID: 20237508
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
16. Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.
Kamata M; Liu S; Liang M; Nagaoka Y; Chen IS
Hum Gene Ther; 2010 Nov; 21(11):1555-67. PubMed ID: 20524893
[TBL] [Abstract][Full Text] [Related]
17. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors.
Barrette S; Douglas JL; Seidel NE; Bodine DM
Blood; 2000 Nov; 96(10):3385-91. PubMed ID: 11071632
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.
Wang GZ; Goff SP
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
